Skip to main content
NextCure, Inc. logo

NextCure, Inc. — Investor Relations & Filings

Ticker · NXTC ISIN · US65343E1082 LEI · 549300Y5PR6RJR1STI24 US Manufacturing
Filings indexed 349 across all filing types
Latest filing 2025-07-28 Regulatory Filings
Country US United States of America
Listing US NXTC

About NextCure, Inc.

https://www.nextcure.com/

NextCure, Inc. is a clinical-stage biopharmaceutical company focused on the discovery and development of novel, first-in-class immunomedicines for the treatment of cancer. The company's research is centered on identifying new immune targets and pathways to create therapies for patients who do not respond to or have relapsed after treatment with existing immunotherapies. NextCure's pipeline includes antibody-drug conjugates (ADCs) and other innovative immunotherapies designed to restore normal immune function and address significant unmet medical needs in oncology.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2025
Regulatory Filings
2025-07-28 English
Regulatory Filings 2025
Regulatory Filings
2025-07-24 English
S-3
Registration Form
2025-07-18 English
8-K
Regulatory Filings
2025-07-14 English
8-K
Regulatory Filings
2025-07-10 English
Director's Dealing 2025
Director's Dealing
2025-06-24 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.